Activate Now
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Netwo...

How One LLND Treats Lyme disease and Co-infections Using Natural Medicine

Top 7 Nutrient-Dense Foods That Make Calorie Counting Obsolete

Acupuncture reduces hot flashes in breast cancer survivors

For veterans with Gulf War Illness, an explanation for the unexplainable symptoms

SURVEY: Has Your Illness Affected What You Eat?

DePaul Study Recruiting Participants

VIDEO: Dr. Horowitz Discusses Lyme Disease and Chronic Illness

Cocoa flavanols lower blood pressure and increase blood vessel function in healthy people

Detection of Invasive Borrelia burgdorferi Strains in North-Eastern Piedmont, Italy.

Print Page
Email Article

Multiple Sclerosis Trial Alert: Investigators Recruiting 1,260 People with MS for Study of PEGylated Interferon Beta-1a

  [ 3 votes ]   [ Discuss This Article ]
By National Multiple Sclerosis Society • • September 10, 2009

Source: National Multiple Sclerosis Society trial announcement (, Aug 31, 2009

Summary: Investigators worldwide are recruiting 1,260 people with relapsing MS for a Phase III clinical trial comparing the effectiveness of BIIB017 (PEGylated interferon beta-1a, delivered under the skin) and inactive placebo. The study is sponsored by Biogen Idec.

Rationale: Avonex® (interferon beta-1a, Biogen Idec) is approved by the U.S. Food and Drug Administration for the treatment of people with relapsing forms of MS to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations. BIIB017 is a “pegylated” form of the interferon beta-1a molecule. PEGylated molecules are attached to a molecule of polyethylene glycol, which enables them to maintain effects in the body for longer periods of time.

This formulation has been tested in healthy individuals in two phase I clinical trials, but has not yet been tested in people with MS. If proven to be safe and effective in treating MS, this drug may help to reduce the frequency of administration of interferon beta and the flu-like side effects that can occur with each treatment.

Eligibility and Details: Investigators are seeking participants aged 18 to 55 who have experienced at least two relapses that have been medically documented within the last three years, with one occurring in the last 12 months.

Participants will be randomly assigned to one of three groups, for a study period of approximately two years and three months:
• Placebo
• BIIB017 125 mg delivered subcutaneously (under the skin) every two weeks
• BIIB017 125 mg delivered subcutaneously every four weeks

The primary objective of the study is to determine the effects of the drug versus placebo on the annualized relapse rate. Secondary objectives include the effects on tissue damage as observed on MRI scans, quality of life, and disease progression as measured by the EDSS scale.

Contact: To learn more about the enrollment criteria for this study, and to find out if you are eligible to participate, please email As of now, sites are located in the following cities in the United States:

Lexington, KY
Dallas, TX
Akron, OH
Raleigh, NC
Franklin, TN
St Petersburg, FL
Atlanta, GA
Round Rock, TX

To download a brochure discussing issues to think about when considering enrolling in an MS clinical trial (PDF), see the trial listing at the National MS Society site.

Please Discuss This Article:   Post a Comment 

[ Be the first to comment on this article ]

Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

Vitamins and Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10 Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10
Breaking Through the Mental Fog Breaking Through the Mental Fog
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery

What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
M.E. & CFS
Lyme Disease
General Health
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing